Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

Sponsor
Anne-Sophie Brazeau
Study ID
NCT05910840
Status
Recruiting
Apply to this trial

Conditions

  • Autoimmune Diseases
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 1
  • Endocrine System Diseases
  • Glucose Metabolism Disorders (Including Diabetes Mellitus)
  • Immune System Diseases
  • Metabolic Disease

Eligibility Criteria

Sex
ALL
Age
14 Years - 16 Years
Healthy Volunteers
Not accepted

Interventions

  • Support-t — OTHER
    Support-t plus usual diabetes care for 18 months

Study Details

The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in the province of Quebec.

Key Dates

First listed
Jun 20, 2023
Start date
Oct 7, 2024
Status verified
Sep 2025
Primary completion
Apr 30, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Support-t plus usual diabetes care
    Access to the Support-t online training and peer support platform in addition to usual diabetes care for 18 months. Support-t contains 3 components: 1) Educational material, 2) News blog and 3) Patients' discussion forum. Health care providers from the pediatric diabetes clinics will receive Support-t training and will be encouraged to recommend the Support-t platform during routine care with their patients from the active arm.
  • No Intervention: Usual diabetes care only
    Usual diabetes care for 18 months, which consists of visits with their health care provider and ad-hoc diabetes education with nurses and dietitians. Health care providers from the pediatric diabetes clinics will be instructed not to discuss or refer to the Support-t platform with patients from the control arm. Control arm participants will have the option to use the Support-t platform after the 18-month study.

Primary Outcome Measure

Change from Baseline Hemaglobin A1c (HbA1c) at 18 months [ Time Frame: 18 months ]

Central Contacts

Find similar trials

Nationwide
Type 1 diabetes trialsEndocrinology trials

Related Studies